Chemical Hygiene Plan Ii Revised 03/2021 Table of Contents
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Nanomaterial Safety
Nanomaterial Safety What are Nanomaterials? Nanomaterials or nanoparticles are human engineered particles with at least one dimension in the range of one to one hundred nanometers. They can be composed of many different base materials (carbon, silicon, and various metals). Research involving nanomaterials ranges from nano-particle synthesis to antineoplastic drug implants to cell culture work. Material Scientists, Chemists, Biologists, Biochemists, Physicists, Microbiologists, Medical-related disciplines and many engineering disciplines (Mechanical, Chemical, Biological and Environmental, etc.) perform research using nanomaterials. Naturally created particles of this size range are normally called ultra-fine particles. Examples are welding fumes, volcanic ash, motor vehicle exhaust, and combustion products. Nanomaterials come in many different shapes and dimensions, such as: • 0-dimensional: quantum dots • 1-dimensional: nanowires, nanotubes, • 2-dimensional: nanoplates, nanoclays • 3-dimensional: Buckyballs, Fullerenes, nanoropes, crystalline structures Nanoparticles exhibit very different properties than their respective bulk materials, including greater strength, conductivity, fluorescence and surface reactivity. Health Effects Results from studies on rodents and in cell cultures exposed to ultrafine and nanoparticles have shown that these particles are more toxic than larger ones on a mass-for-mass basis. Animal studies indicate that nanoparticles cause more pulmonary inflammation, tissue damage, and lung tumors than larger particles Solubility, shape, surface area and surface chemistry are all determinants of nanoparticle toxicity There is uncertainty as to the levels above which these particles become toxic and whether the concentrations found in the workplace are hazardous Respiratory Hazards: • Nanoparticles are deposited in the lungs to a greater extent than larger particles • Based on animal studies, nanoparticles may enter the bloodstream from the lungs and translocate to other organs and they are able to cross the blood brain barrier. -
TR-499: Indium Phosphide (CASRN 22398-80-7) in F344/N Rats And
NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF INDIUM PHOSPHIDE (CAS NO. 22398-80-7) IN F344/N RATS AND B6C3F1 MICE (INHALATION STUDIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 July 2001 NTP TR 499 NIH Publication No. 01-4433 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health FOREWORD The National Toxicology Program (NTP) is made up of four charter agencies of the U.S. Department of Health and Human Services (DHHS): the National Cancer Institute (NCI), National Institutes of Health; the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health; the National Center for Toxicological Research (NCTR), Food and Drug Administration; and the National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention. In July 1981, the Carcinogenesis Bioassay Testing Program, NCI, was transferred to the NIEHS. The NTP coordinates the relevant programs, staff, and resources from these Public Health Service agencies relating to basic and applied research and to biological assay development and validation. The NTP develops, evaluates, and disseminates scientific information about potentially toxic and hazardous chemicals. This knowledge is used for protecting the health of the American people and for the primary prevention of disease. The studies described in this Technical Report were performed under the direction of the NIEHS and were conducted in compliance with NTP laboratory health and safety requirements and must meet or exceed all applicable federal, state, and local health and safety regulations. Animal care and use were in accordance with the Public Health Service Policy on Humane Care and Use of Animals. -
Spectrophotometric Determination of Thiocyanate In
Investigative Forensic Sciences © All rights are reserved by Buddha D. Paul and Thomas Research Article Open Access Spectrophotometric Determination of Thiocyanate in Human Saliva by a Unique Iodine-Azide-Chromogenic Substrate Reaction and its Application in Distinguishing Tobacco Smokers from Non-Smokers† Buddha D. Paul and Thomas Bosy Division of Forensic Toxicology, Office of the Armed Forces Medical Examiner, Dover AFB, Delaware, USA. Abstract A method to detect thiocyanate (SCN) in human saliva is presented. Thiocyanate concentrations appear to be diagnostic when classifying smokers or non-smokers, and in determining some clinical conditions. The method involves the reaction of SCN with excess iodine and azide, and spectroscopic detection of unreacted iodine by a chromogenic substrate, ABTS. The calibration was linear over the range of 12.5-150 µmol/L (slope = 0.0086 delta-Abs/SCN µmol/L, intercept = -0.0160 delta-Abs, R2 0.9998). The method was applied to analyze 29 saliva specimens. The results were similar to those obtained from a gas chromatography-mass 2 spectrometry method (slope = 0.9595, R 0.9790). Based on Grubbs equation applied to specimens from non-smoking subjects, a threshold concentration of 1100 µmol/L for SCN was determined to distinguish smokers from the non-smokers. The SCN concentrations in 18 out of 20 saliva specimens collected from 2 smokers were above this threshold. The specimens from smokers were also examined for nicotine and cotinine by a GCMS method. While nicotine concentrations were found to vary, the cotinine concentrations remained stable, 134+29 ng/mL. Generally, the presence of nicotine/cotinine in specimens only indicates exposure to tobacco products, but the presence of any of these compounds with elevated SCN, is an indication of smoking. -
Patient Education Guide
Patient Education Guide Guidance and support to help you manage your gastrostomy tube (g-tube) Balloon ® Mini ONE Buttons The Leader in Enteral Device Innovation Contents Balloon Mini ONE® Button 2 How the Balloon Mini ONE® Button is Different 17 Decompression (Venting the 4 Balloon Mini ONE® Button Kit Contents Stomach / Releasing Gas) 18 G-Tube Related Concerns 6 Attaching Feed Sets 22 Stoma Site Related Concerns 8 Feeding with Your Mini ONE® Feeding Tube 23 Administering Medications 10 Stoma Site Care / Button Maintenance 24 Feeding Sets and Accessories 12 Replacing the Balloon Mini ONE® Button 25 Re-Ordering Information 16 Special Concerns for Children 1 Introduction to Tube Feeding Proper nutrition is essential to maintaining our bodies’ health, growth and ability to heal. Various medical conditions may make it difficult or impossible for a person to eat, and thus deny the body of essential nutrients. In such cases, a gastrostomy tube (g-tube) is inserted to provide direct access to the stomach for feeding. A g-tube is a convenient, comfortable and effective means for delivering nutritional formulas to the George J. Picha, body. These nutritional formulas are either commercially available or homemade using M.D., Ph.D., F.A.C.S. a food processor. A physician will prescribe the proper feeding procedure, formula Founder of AMT and Co-inventor of the and amount of water to most effectively feed each patient. first Button low profile feeding device. Comfort and Confidence are Important, Too AMT specializes in enteral devices, our As a caregiver or patient, we believe you have a right to the most comfortable core business. -
Calarp) Program
California Accidental Release Prevention (CalARP) Program Administering Agency Guidance January 31, 2005 Preface This document provides general guidance to help Administering Agencies (AAs) implement and enforce the California Accidental Release Prevention (CalARP) Program. The intent is to identify the elements of the Program applicable to each regulated business, and assist AAs with oversight of the CalARP Program statutes and regulations. This document is not a substitute for the CalARP Program regulations; it does not impose legally binding requirements. About This Document This document follows the format of the California Code of Regulations, Title 19, Division 2, Chapter 4.5: California Accidental Release Prevention (CalARP) Program. The regulatory sections are presented in parentheses for ease of reference. Acknowledgements The California Emergency Management Agency (Cal EMA) would like to thank the following people for their valuable assistance in the preparation of this document: Howard Wines, Hazardous Materials Specialist, City of Bakersfield Fire Department Robert Distaso P.E., Fire Safety Engineer, Orange County Fire Authority Randall L. Sawyer, Supervisor, Accidental Release Prevention Programs, Contra Costa County Health Services Department Beronia Beniamine, Senior Hazardous Materials Specialist, Stanislaus County Environmental Resources Department Angie Proboszcz, Risk Management Program Coordinator, USEPA Region 9 Jon Christenson, Senior Environmental Health Specialist, Merced County Department of Public Health Teresa -
Content Production and Management by Applying Artificial Intelligence Techniques for Content Composition, Representation (Format) and Workflow; Ii
IST-2-511299 Automating Production of Cross Media Content for Multi-channel Distribution www.AXMEDIS.org CCoonntteenntt PPrroodduuccttiioonn Version: 1.0 URL: http://www.axmedis.org/ David Luigi FUSCHI GIUNTI Interactive Labs Laurence PEARCE XIM AXMEDIS: Automating Production of Cross Media Content for Multi-channel Distribution www.AXMEDIS.org 1 Preface Digital-content market is urging better pricing and value-for-money for industry products and services. This is clearly evident in the recent price reductions by major companies in the sector. The containment of sale prices is a vital key when setting up a viable and sustainable business venture in the digital cross media content. Possible solutions to this challenge could be found by automating, accelerating and re- structuring production processes, and providing solution to the content protection. Such solutions will en- able the production processes to be faster and cheaper, while at the same time providing new capabilities to support safer distribution. AXMEDIS aims to meet the challenges of market demand by: i. reducing costs for content production and management by applying Artificial Intelligence techniques for content composition, representation (format) and workflow; ii. reducing distribution and aggregation costs in order to increase accessibility with a Peer-to-Peer (P2P) platform at Business-to-Business (B2B) level, which can integrate content management sys- tems and workflows; iii. providing new methods and tools for innovative and flexible Digital Rights Management (DRM), -
Francis (Bud) J. Offermann III PE, CIH
Francis (Bud) J. Offermann III PE, CIH Indoor Environmental Engineering 1448 Pine Street, Suite 103, San Francisco, CA 94109 Phone: 415-567-7700 Email: [email protected] http://www.iee-sf.com Education M.S. Mechanical Engineering (1985) Stanford University, Stanford, CA. Graduate Studies in Air Pollution Monitoring and Control (1980) University of California, Berkeley, CA. B.S. in Mechanical Engineering (1976) Rensselaer Polytechnic Institute, Troy, N.Y. Professional Experience President: Indoor Environmental Engineering, San Francisco, CA. December, 1981 - present. Direct team of environmental scientists, chemists, and mechanical engineers in conducting State and Federal research regarding indoor air quality instrumentation development, building air quality field studies, and ventilation and air cleaning performance measurements. Direct work of IAQ Diagnostic and Mitigation team of industrial hygienists, mechanical engineers, and building inspectors and abatement planners addressing the concerns of building developers, owners, operators, managers, tenants, architects, and ventilation engineers regarding indoor air quality and appropriate and cost effective mitigation measures where required. Manage the Mobile Response Group, a group of hygienists and engineers trained to provide timely and cost effective building inspections and abatement plans nationwide. Provide design side input to architects regarding selection of building materials and ventilation system components to ensure a superior indoor environment. Developed tracer gas techniques used to evaluate the in situ performance of mechanical ventilation systems. Developed a dynamic headspace analytical technique to quantify the in situ emission rates of contaminants from building materials, furnishings, and equipment. Developed ground flux measurement techniques for assessing the potential impact on indoor air quality of ground contaminants (e.g. -
The Atmospheric Chemical Vapour Deposition of Coatings on Glass
The Atmospheric Chemical Vapour Deposition Of Coatings On Glass. by Kevin David Sanderson, B.Sc. A thesis submitted to Imperial College of Science Technology and Medicine for the degree of Doctor of Philosophy January, 1996 The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author. Some of the material presented in this thesis is of a confidential nature. It is therefore requested that anyone reading this thesis maintains this confidentiality until the thesis becomes publicly available. Abstract: The deposition of thin films of indium oxide, tin doped indium oxide (ITO) and titanium nitride for solar control applications have been investigated by Atmospheric Chemical Vapour Deposition (APCVD). Experimental details of the deposition system and the techniques used to characterise the films are presented. Results from investigations into the deposition parameters, the film microstructure and film material properties are discussed. A range of precursors were investigated for the deposition of indium oxide. The effect of pre-mixing the vaporised precursor with an oxidant source and the deposition temperature has been studied. Polycrystalline In203 films with a resistivity of 1.1 - 3 x 10-3 ) cm were obtained with In(thd)3 , oxygen and nitrogen. The growth of ITO films from In(thd)3, oxygen and a range of tin dopants is also presented. The effect of the dopant precursor, the doping concentration, deposition temperature and the effect of additives on film growth and microstructure is discussed. Control over the preferred orientation growth of ITO has been achieved by the addition of acetate species during film growth. -
Permit Review Report Permit ID: 3-3926-00729/00054 Renewal Number: 2 Modification Number: 3 01/18/2019
New York State Department of Environmental Conservation Permit Review Report Permit ID: 3-3926-00729/00054 Renewal Number: 2 Modification Number: 3 01/18/2019 Facility Identification Data Name: PAR PHARMACEUTICAL INC Address: 1 RAM RIDGE RD CHESTNUT RIDGE, NY 10977 Owner/Firm Name: PAR PHARMACEUTICAL INC Address: 1 RAM RIDGE RD CHESTNUT RIDGE, NY 10977, USA Owner Classification: Corporation/Partnership Permit Contacts Division of Environmental Permits: Name: CHRISTOPHER LANG Address: NYSDEC - REGION 3 21 S PUTT CORNERS RD NEW PALTZ, NY 12561-5401 Phone: Division of Air Resources: Name: ALYSSA CARBONE Address: NYSDEC - REGION 3 21 S Putt Corners Rd New Paltz, NY 12561-1620 Phone:8452563058 Air Permitting Contact: Name: TODD ARNOLD Address: 1 RAM RIDGE RD CHESTNUT RIDGE, NY 10977 Phone:8453644868 Permit Description Introduction The Title V operating air permit is intended to be a document containing only enforceable terms and conditions as well as any additional information, such as the identification of emission units, emission points, emission sources and processes, that makes the terms meaningful. 40 CFR Part 70.7(a)(5) requires that each Title V permit have an accompanying "...statement that sets forth the legal and factual basis for the draft permit conditions". The purpose for this permit review report is to satisfy the above requirement by providing pertinent details regarding the permit/application data and permit conditions in a more easily understandable format. This report will also include background narrative and explanations of regulatory decisions made by the reviewer. It should be emphasized that this permit review report, while based on information contained in the permit, is a separate document and is not itself an enforceable term and condition of the permit. -
Solubility and Solution-Phase Chemistry of Isocyanic Acid, Methyl Isocyanate, 2 and Cyanogen Halides 3 4 5 6 James M
Atmos. Chem. Phys. Discuss., https://doi.org/10.5194/acp-2018-1160 Manuscript under review for journal Atmos. Chem. Phys. Discussion started: 9 November 2018 c Author(s) 2018. CC BY 4.0 License. 1 Solubility and Solution-phase Chemistry of Isocyanic Acid, Methyl Isocyanate, 2 and Cyanogen Halides 3 4 5 6 James M. Roberts1, and Yong Liu2 7 8 1. NOAA/ESRL Chemical Sciences Division, Boulder, Colorado, 80305 9 2. Department of Chemistry, University of Colorado, Denver, Denver, Colorado, 80217 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 Atmos. Chem. Phys. Discuss., https://doi.org/10.5194/acp-2018-1160 Manuscript under review for journal Atmos. Chem. Phys. Discussion started: 9 November 2018 c Author(s) 2018. CC BY 4.0 License. 52 Abstract 53 54 Condensed phase uptake and reaction are important atmospheric removal processes for reduced nitrogen 55 species, isocyanic acid (HNCO), methyl isocyanate (CH3NCO) and cyanogen halides (XCN, X =Cl, Br, I), yet many 56 of the fundamental quantities that govern this chemistry have not been measured or are understudied. Solubilities 57 and first-order reaction rates of these species were measured for a variety of solutions using a bubble flow reactor 58 method with total reactive nitrogen (Nr) detection. The aqueous solubility of HNCO was measured as a function of 59 pH, and exhibited the classic behavior of a weak acid, with an intrinsic Henry’s law solubility of 20 (±2) M/atm, and -4 60 a Ka of 2.0 (±0.28) ×10 M (which corresponds to pKa = 3.7 ±0.06) at 298K. -
IODINE Its Properties and Technical Applications
IODINE Its Properties and Technical Applications CHILEAN IODINE EDUCATIONAL BUREAU, INC. 120 Broadway, New York 5, New York IODINE Its Properties and Technical Applications ¡¡iiHiüíiüüiütitittüHiiUitítHiiiittiíU CHILEAN IODINE EDUCATIONAL BUREAU, INC. 120 Broadway, New York 5, New York 1951 Copyright, 1951, by Chilean Iodine Educational Bureau, Inc. Printed in U.S.A. Contents Page Foreword v I—Chemistry of Iodine and Its Compounds 1 A Short History of Iodine 1 The Occurrence and Production of Iodine ....... 3 The Properties of Iodine 4 Solid Iodine 4 Liquid Iodine 5 Iodine Vapor and Gas 6 Chemical Properties 6 Inorganic Compounds of Iodine 8 Compounds of Electropositive Iodine 8 Compounds with Other Halogens 8 The Polyhalides 9 Hydrogen Iodide 1,0 Inorganic Iodides 10 Physical Properties 10 Chemical Properties 12 Complex Iodides .13 The Oxides of Iodine . 14 Iodic Acid and the Iodates 15 Periodic Acid and the Periodates 15 Reactions of Iodine and Its Inorganic Compounds With Organic Compounds 17 Iodine . 17 Iodine Halides 18 Hydrogen Iodide 19 Inorganic Iodides 19 Periodic and Iodic Acids 21 The Organic Iodo Compounds 22 Organic Compounds of Polyvalent Iodine 25 The lodoso Compounds 25 The Iodoxy Compounds 26 The Iodyl Compounds 26 The Iodonium Salts 27 Heterocyclic Iodine Compounds 30 Bibliography 31 II—Applications of Iodine and Its Compounds 35 Iodine in Organic Chemistry 35 Iodine and Its Compounds at Catalysts 35 Exchange Catalysis 35 Halogenation 38 Isomerization 38 Dehydration 39 III Page Acylation 41 Carbón Monoxide (and Nitric Oxide) Additions ... 42 Reactions with Oxygen 42 Homogeneous Pyrolysis 43 Iodine as an Inhibitor 44 Other Applications 44 Iodine and Its Compounds as Process Reagents ... -
Used at Rocky Flats
. TASK 1 REPORT (Rl) IDENTIFICATION OF CHEMICALS AND RADIONUCLIDES USED AT ROCKY FLATS I PROJECT BACKGROUND ChemRisk is conducting a Rocky Flats Toxicologic Review and Dose Reconstruction study for The Colorado Department of Health. The two year study will be completed by the fall of 1992. The ChemRisk study is composed of twelve tasks that represent the first phase of an independent investigation of off-site health risks associated with the operation of the Rocky Flats nuclear weapons plant northwest of Denver. The first eight tasks address the collection of historic information on operations and releases and a detailed dose reconstruction analysis. Tasks 9 through 12 address the compilation of information and communication of the results of the study. Task 1 will involve the creation of an inventory of chemicals and radionuclides that have been present at Rocky Flats. Using this inventory, chemicals and radionuclides of concern will be selected under Task 2, based on such factors as the relative toxicity of the materials, quantities used, how the materials might have been released into the environment, and the likelihood for transport of the materials off-site. An historical activities profile of the plant will be constructed under Task 3. Tasks 4, 5, and 6 will address the identification of where in the facility activities took place, how much of the materials of concern were released to the environment, and where these materials went after the releases. Task 7 addresses historic land-use in the vicinity of the plant and the location of off-site populations potentially affected by releases from Rocky Flats.